#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia positive acute lymphocytic leukaemia Langerhans cell sarcoma Non-small cell lung cancer metastatic Haemophilia B with anti factor IX Von Willebrand's disease Macular telangiectasia Warm autoimmune haemolytic anaemia PIK3CA-activated mutation Alveolar rhabdomyosarcoma Glomerulonephritis Skin cancer Soft tissue necrosis Niemann-Pick disease Non-Hodgkin's lymphoma Anti-myelin-associated glycoprotein associated polyneuropathy More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy – Trials in Disease Hereditary ataxia – Life with Disease Factor VIII deficiency – Basic Information Alternating hemiplegia of childhood – Life with Disease Arterial tortuosity syndrome – Life with Disease Adrenogenital syndrome – Treatment Methylmalonic acidaemia – Basic Information Mucopolysaccharidosis – Treatment Mastocytosis – Life with Disease Behcet’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Irinotecan Ab-1002 Timolol Ranolazine YOHIMBINE HYDROCHLORIDE Human Normal Immunoglobulin Gskvx000000014593 INCB123667 Insulin Icodec Lenacapavir Hct116-A Cln-081 Abc-15A-116 Other Immunosuppressants Boserolimab Plerixafor VANADIUM OXIDE SULFATE Vinorelbine Tartrate Odevixibat Mps-213 More therapies…

    Learn about Your Condition

    Rectosigmoid cancer Erythema migrans Rabies Plasmablastic lymphoma Renal injury Immune-mediated renal disorder Thyroid cancer Cystic fibrosis lung Eosinophilic gastritis Cancer pain Developmental hip dysplasia Colorectal adenoma Neuroblastoma Cushing's syndrome Liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on Esketamine and Diphenhydramine for Treating Depression and Negative Symptoms in Schizophrenia Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Negative symptoms in schizophrenia
    • Schizoaffective disorder depressive type
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Diphenhydramine Hydrochloride
    Austria

  • Study on the Effects of Ketamine and Electroconvulsive Therapy for Patients with Treatment-Resistant Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    • Sodium Chloride
    Italy

  • Study on the Effectiveness of Aripiprazole and Paliperidone in Patients Experiencing Their First Episode of Schizophrenia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Aripiprazole
    • Risperidone
    Spain

  • Study on the Effectiveness of Choline Alfoscerate for Treating Mild Depression in Elderly Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • CHOLINE ALFOSCERATE
    Italy

  • Study on Psilocybin-Assisted Therapy for Patients with Severe Alcohol Use Disorder

    Recruiting

    2 1
    Investigated Diseases:
    • Alcohol abuse
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Belgium

  • Study on ITI-1284 for Patients with Generalized Anxiety Disorder Not Responding to Current Treatment

    Recruiting

    2 1
    Investigated Diseases:
    • Generalised anxiety disorder
    Investigated Drugs:
    • Iti-1284
    Bulgaria Czechia Finland Poland
Previous Page
1 … 9 10 11 12 13 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!